Source: Annual Congress 2005 - Information for the active clinician



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sonobe, H. Miyamoto, H. Izumi, B. Nobukawa, T. Futagawa (Tokyo, Japan). Clinicopathological features in thymoma-associated autoimmune disease. Eur Respir J 2005; 26: Suppl. 49, 2798

Member's Comments

No comment yet.

Related content which might interest you: Non-organ-specific manifestations of sarcoidosis Source: Eur Respir Monogr 2022; 96: 206-222 Year: 2022 Clinical features of interstitial lung disease in polymyositis and dermatomyositis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006 Sarcoidosis and autoimmune thyroid disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Progressive course of asthma in patients with autoimmune thyroiditis Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Clinical features and outcomes of patients with myositis associated-interstitial lung disease Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Bronchiectasis and autoimmune disease Source: Eur Respir Mon 2011; 52: 192-210 Year: 2011 Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005 Interstitial pneumonia with autoimmune features (IPAF): the relationship between radiological and clinical features Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Thoracic manifestations of systemic autoimmune diseases: radiological findings Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 The autoimmune criteria of sarcoidosis Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology Year: 2020 Predictors of asthma progressive course in patients with autoimmune thyroiditis Source: Eur Respir J 2007; 30: Suppl. 51, 554s Year: 2007 Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019 Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002 Manifestations of malignancies during the course of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011 Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Clinical, functional and radiologic progression in Interstitial pneumonia with autoimmune features (IPAF): a prospective cohort-study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)? Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 Interstitial lung disease associated with autoimmune thyroiditis (ILD-AT) Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012